| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Clinical Chemistry, Vol 39, 138-142, Copyright © 1993 by American Association for Clinical Chemistry
CW Weykamp, TJ Penders, CW Siebelder, FA Muskiet and W van der Slik
Department of Clinical Chemistry, Queen Beatrix Hospital, Winterswijk, The Netherlands.
In vitro-synthesized carbamylated and acetylated hemoglobins interfered in assays of glycohemoglobin by HPLC and electrophoresis but had no effects on results obtained by affinity chromatography and enzyme immunoassay. Correlations between long-term serum urea concentrations and glycohemoglobin percentages revealed that, in vivo, carbamylated hemoglobin equivalent to 0.063% of total hemoglobin is formed for every 1 mmol/L of serum urea. The use of acetylsalicylate, either chronically in small doses (200-300 mg/day) or for 1 week at 2000 mg/day, did not cause significant interference from acetylhemoglobin, formed in vivo. We conclude that interference from carbamylated hemoglobin explains only a small part of existing discrepancies between results of glycohemoglobin assays in current use. The interfering effect of acetylhemoglobin formed in vivo with acetyl-CoA as substrate is as yet unknown.
The following articles in journals at HighWire Press have cited this article:
|
|
 |
|
  E S Kilpatrick Haemoglobin A1c in the diagnosis and monitoring of diabetes mellitus J. Clin. Pathol., September 1, 2008; 61(9): 977 - 982. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Tascona, A. R. Morton, E. B. Toffelmire, D. C. Holland, and E. A. Iliescu Adequacy of Glycemic Control in Hemodialysis Patients With Diabetes Diabetes Care, October 1, 2006; 29(10): 2247 - 2251. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E S Kilpatrick HbA1c measurement J. Clin. Pathol., April 1, 2004; 57(4): 344 - 345. [Full Text] [PDF]
|
|
|
|
 |
|
 L. Bry, P. C. Chen, and D. B. Sacks Effects of Hemoglobin Variants and Chemically Modified Derivatives on Assays for Glycohemoglobin Clin. Chem., February 1, 2001; 47(2): 153 - 163. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Krone and J. T.A. Ely Vitamin C and Glycohemoglobin Revisited Clin. Chem., January 1, 2001; 47(1): 148 - 148. [Full Text] [PDF]
|
|
|
|
|
|
I. Gibb, A. Parnham, M. Fonfrede, and F. Lecock Multicenter Evaluation of Tosoh Glycohemoglobin Analyzer Clin. Chem., October 1, 1999; 45(10): 1833 - 1841. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. W. Weykamp, K. Miedema, T. de Haan, and C. J.A. Doelman Carbamylated Hemoglobin Interference in Glycohemoglobin Assays Clin. Chem., March 1, 1999; 45(3): 438 - 440. [Full Text] [PDF]
|
|
|
|
|
|
D. Chen, D. L. Crimmins, F. F. Hsu, F. P. Lindberg, and M. G. Scott Hemoglobin Raleigh as the cause of a falsely increased hemoglobin A1C in an automated ion-exchange HPLC method Clin. Chem., June 1, 1998; 44(6): 1296 - 1301. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. A. Doelman, C. W. M. Siebelder, W. A. Nijhof, C. W. Weykamp, J. Janssens, and T. J. Penders Capillary electrophoresis system for hemoglobin A1c determinations evaluated Clin. Chem., April 1, 1997; 43(4): 644 - 648. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Holownia, E. Bishop, D. J. Newman, W. G. John, and C. P. Price Adaptation of latex-enhanced assay for percent glycohemoglobin to a Dade Dimension(R) analyzer Clin. Chem., January 1, 1997; 43(1): 76 - 84. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
